GSA Capital Partners’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-37,452
| Closed | -$56K | – | 2069 |
|
|
2023
Q1 | $56K | Buy |
+37,452
| New | +$56K | 0.01% | 1396 |
|
|
2022
Q2 | – | Sell |
-158,593
| Closed | -$438K | – | 1935 |
|
|
2022
Q1 | $438K | Buy |
158,593
+84,191
| +113% | +$233K | 0.06% | 630 |
|
|
2021
Q4 | $347K | Buy |
74,402
+823
| +1% | +$3.84K | 0.04% | 842 |
|
|
2021
Q3 | $626K | Buy |
73,579
+41,637
| +130% | +$354K | 0.06% | 552 |
|
|
2021
Q2 | $524K | Buy |
31,942
+21,917
| +219% | +$360K | 0.06% | 593 |
|
|
2021
Q1 | $221K | Buy |
10,025
+3,237
| +48% | +$71.4K | 0.04% | 840 |
|
|
2020
Q4 | $210K | Buy |
+6,788
| New | +$210K | 0.03% | 962 |
|